Latest Earnings Analysis
-
BlackSky (BKSY) Q3 2023: $252M Backlog and 98% Incremental Margins Signal Operating Leverage Inflection
November 08, 2023 · BKSY
-
AFC Gamma (AFCG) Q3 2023: Portfolio Yield Sustains 19% as Cannabis Lending Pipeline Rebounds
November 08, 2023 · AFCG
-
Angi (ANGI) Q3 2023: Marketplace Shift Drives 11% Drop in Monetized Transaction Revenue, Refocuses on Quality
November 08, 2023 · ANGI
-
BrightHouse Financial (BHF) Q3 2023: SHIELD Annuity Sales Jump 15% Amid Capital Buffer Shift
November 08, 2023 · BHF
-
BARK (BARK) Q2 2024: Gross Margin Jumps 560bps as Consumables Expansion Offsets Toy Headwinds
November 08, 2023 · BARK
-
AdaptHealth (AHCO) Q3 2023: Sleep Revenue Jumps 17% as Humana Transition Delays Margin Lift
November 07, 2023 · AHCO
-
AWR Q3 2023: $611M Water CapEx Request Signals 24% Rate Hike Push
November 07, 2023 · AWR
-
Axogen (AXGN) Q3 2023: Core Accounts Expand 12% as Scheduled Procedures Surge
November 07, 2023 · AXGN
-
Axon (AXON) Q3 2023: Cloud Revenue Jumps 55% as Federal Bookings Crack Top 5 Deal List
November 07, 2023 · AXON
-
Brink’s (BCO) Q3 2023: AMS and DRS Revenue Hits 20% of Mix, Driving 230bps Margin Expansion
November 07, 2023 · BCO
-
BCSF Q3 2023: 95% Portfolio Outperforms Underwrite as First Lien Focus Drives Resilience
November 07, 2023 · BCSF
-
Angel Oak Mortgage (AOMR) Q3 2023: Warehouse Debt Down 69% as NIM Expansion Accelerates
November 07, 2023 · AOMR
-
Biodesix (BDSX) Q3 2023: Lung Test Volumes Surge 60%, Margin Leverage Accelerates Path to Profitability
November 07, 2023 · BDSX
-
Air Products (APD) Q4 2023: $19B Backlog Anchors Double-Digit EPS Growth Amid $7B Louisiana Hydrogen Bet
November 07, 2023 · APD
-
American Public Education (APEI) Q3 2023: APUS Margin Surges to 30% as Cost Discipline Reshapes Portfolio
November 07, 2023 · APEI
-
AQST Q3 2023: Revenue Jumps 42% as Debt Recast Extends Runway for Anafilm Launch
November 07, 2023 · AQST
-
ARKO (ARKO) Q3 2023: Loyalty Membership Jumps 50%, Fueling Margin Expansion Despite Gallon Decline
November 07, 2023 · ARKO
-
Array Technologies (ARRY) Q3 2023: Gross Margin Rises 560bps as Pipeline Doubles Despite $300M Project Delays
November 07, 2023 · ARRY
-
Ardmore Shipping (ASC) Q3 2023: Spot Exposure Lifts TCE Rates 6% as Market Inflects
November 07, 2023 · ASC
-
Ascendis Pharma (ASND) Q3 2023: Skytrofa Revenue Climbs 31%, Pipeline Expansion Sets Stage for 2024 Launches
November 07, 2023 · ASND
-
A10 Networks (ATEN) Q3 2023: Enterprise Revenue Climbs 7% as Service Provider Headwinds Persist
November 07, 2023 · ATEN
-
Amplify Energy (AMPY) Q3 2023: Net Debt Cut by 43% as Beta Output and Cost Control Drive Strategic Flexibility
November 07, 2023 · AMPY
-
Amplitude (AMPL) Q3 2023: Plus Plan Drives Five-Figure Signups, Refocusing Sales on Enterprise Expansion
November 07, 2023 · AMPL
-
Altimmune (ALT) Q3 2023: R&D Spend Drops 9% as Obesity and NASH Programs Advance Toward Key Data
November 07, 2023 · ALT
-
Akamai (AKAM) Q3 2023: Security Revenue Jumps 20% as Edge Cloud Strategy Drives Mix Shift
November 07, 2023 · AKAM
-
Arteris (AIP) Q3 2023: FlexNOC 5 Drives 33% ASP Uplift Amid 22 New Design Wins
November 07, 2023 · AIP
-
Albany International (AIN) Q3 2023: Heimbach Adds $16M Revenue, Integration Drives 2025 Accretion Path
November 07, 2023 · AIN
-
AGEN (AGEN) Q3 2023: $200M Non-Dilutive Cash Plan Extends Runway as BLA Filing Nears
November 07, 2023 · AGEN
-
Advantage Solutions (ADV) Q3 2023: Marketing Segment Jumps 16%, Unlocking Experiential Growth Path
November 07, 2023 · ADV
-
ADTN Q3 2023: $180M Cash Generation Plan Reshapes Capital Allocation Amid Optical Weakness
November 07, 2023 · ADTN
-
ADC Therapeutics (ADCT) Q3 2023: 23% Cost Cut Reshapes Path After 33% Zinlonta Sales Slide
November 07, 2023 · ADCT
-
ACMR Q3 2023: Gross Margin Rises to 52.9% on Product Mix and China Mature Node Tailwind
November 07, 2023 · ACMR
-
Accel Entertainment (ACEL) Q3 2023: 7% EBITDA Growth Anchored by New Market Expansion
November 07, 2023 · ACEL
-
Arbutus (ABUS) Q3 2023: 24% Workforce Cut Extends Cash Runway, Refocuses on HBV Pipeline
November 07, 2023 · ABUS
-
Brookdale (BKD) Q3 2023: 10.8% Same-Community REVPAR Surge Signals Margin Expansion Path
November 07, 2023 · BKD
-
Ballard Power Systems (BLDP) Q2 2023: Power Products Backlog Surges 140% as Policy Tailwinds Shift Global Strategy
November 07, 2023 · BLDP
-
Blend (BLND) Q3 2023: Consumer Banking Jumps 18% as Builder Platform Drives Pipeline Expansion
November 07, 2023 · BLND
-
ADEA (ADEA) Q3 2023: 22% Revenue Jump Anchored by Samsung and OTT Renewals, Guidance Narrows on Shaw Dispute
November 06, 2023 · ADEA
-
ATEC (ATEC) Q3 2023: $150M Capital Raise Targets Nonlinear Sales Surge, Margin Expansion Accelerates
November 06, 2023 · ATEC
-
ACVA Q3 2023: Market Share Jumps 15% as Pricing and Transport Margins Outpace Industry
November 06, 2023 · ACVA
-
AOSL Q1 2024: Communications Revenue Jumps 80% QoQ, Offsetting Consumer Correction
November 06, 2023 · AOSL
-
Alto Ingredients (ALTO) Q3 2023: $65M EBITDA Expansion Target Delayed as CapEx Pressures Mount
November 06, 2023 · ALTO
-
Farmer Mac (AGM) Q3 2023: Net Effective Spread Climbs to 120bps, Portfolio Diversification Drives Record Profitability
November 06, 2023 · AGM
-
AMG (AMG) Q3 2023: Alternatives Reach 50% of Earnings as $10B Private Markets Inflows Reshape Profile
November 06, 2023 · AMG
-
Ameresco (AMRC) Q3 2023: $3.7B Backlog Surges 41% as Project Delays Extend Revenue Visibility
November 06, 2023 · AMRC
-
BioNTech (BNTX) Q3 2023: R&D Expenses Rise 46% as Oncology Pipeline Enters Late-Stage Trials
November 06, 2023 · BNTX
-
BAM Q3 2023: Private Credit Fee-Bearing Capital Set to Surge 133% with AEL Integration
November 06, 2023 · BAM
-
AAON (AAON) Q3 2023: Gross Margin Surges to 37% as Backlog Shifts Signal Market Share Gains
November 06, 2023 · AAON
-
Axsome Therapeutics (AXSM) Q3 2023: Prescription Growth Hits 30% as Avelity Expansion Targets 44,000 Prescribers
November 06, 2023 · AXSM
-
AES (AES) Q3 2023: Asset Sale Target Raised to $3.5B, Reinforcing Balance Sheet Flexibility
November 03, 2023 · AES